Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aki Pharma is a pharmaceutical company headquartered in Hyderabad, India, with a significant international presence, including a subsidiary in New Jersey, USA. The company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms for global markets. Their product portfolio covers a wide range of therapeutic areas such as oncology, cardiovascular health, diabetes, and central nervous system disorders. Aki Pharma operates manufacturing facilities that adhere to stringent international quality standards, including US FDA and WHO-GMP certifications. In addition to its own product line, the company offers contract development and manufacturing services (CDMO) to other pharmaceutical entities. Their expertise lies in complex chemical synthesis and process development for high-value small molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AKI Pharma.